MV
Mikkel Viltoft
About Mikkel Viltoft
Data last updated:
Mikkel Viltoft has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Novozymes South Asia Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Novozymes South Asia Private Limited at ₹1,392 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novozymes South Asia Private Limited U24299KA1998PTC024038 | Director | 09 Sep 2009 | 1998 | ₹1,392 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mikkel Viltoft
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mikkel Viltoft
Mikkel Viltoft has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Novozymes South Asia Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Novozymes South Asia Private Limited at ₹1,392 Cr (FY 2025).
Mikkel Viltoft is associated with 1 company as Director, including Novozymes South Asia Private Limited (₹1,392 Cr).
Mikkel Viltoft has expertise in General Business.
Mikkel Viltoft has 17 years in corporate governance.
By reported revenue, the largest current company of Mikkel Viltoft is Novozymes South Asia Private Limited, with revenue of ₹1,392 Cr (FY 2025).
Mikkel Viltoft currently holds positions at 1 company: Novozymes South Asia Private Limited (₹1,392 Cr).